心脏衰竭自我护理管理系统的成本效益
Eisaku Nakane1, Takao Kato2, Nozomi Tanaka2
1Cardiovascular Center, Tazuke Kofukai Medical Research Institute, Kitano Hospital Osaka Japan.
Circulation reports
|January 13, 2025
概括
心力衰竭 (HF) 的自我护理管理系统具有成本效益,可以降低住院和医疗费用,同时提高质量调整寿命 (QALY). 该系统为HF患者提供了有价值,负担得起的治疗选择.
科学领域:
- 心脏病学 心脏病学
- 卫生经济学 卫生经济学
- 医疗技术 医疗技术 医学技术
背景情况:
- 以前的研究表明,心力衰竭 (HF) 的自我护理管理系统可以降低再住院率.
- 这项研究旨在评估实施这种高频自我护理管理系统的经济可行性.
研究的目的:
- 估计心力衰竭 (HF) 自己护理管理系统的成本效益.
- 为了比较心血管医疗保健成本,并计算系统用户和非用户之间的增量成本效益比 (ICER).
主要方法:
- 追溯分析了569名HF患者,其中153名使用者和153名倾向得分匹配的非使用者.
- 经过质量调整的寿命年 (QALYs) 用纽约心脏协会每3个月一次的类和生活质量得分来计算.
- 两个组的心血管医疗保健成本和总成本进行了比较.
主要成果:
- 使用者群体的医疗保健总费用 (¥129,797,016) 与非使用者群体 (¥156,427,032) 相比较低.
- 用户组 (24名患者) 与非用户组 (43名患者) 的住院病例减少.
- 自理系统的使用导致QALYs的增加 (0.653到0.686) 和ICER低于零,表明成本效益.
结论:
- 对心力衰竭 (HF) 的自我护理管理系统证明了显著的成本效益.
- 该系统的实施与改善患者结果 (增加QALY) 和减少医疗保健支出有关.
- 该系统代表了管理心力衰竭的有价值和经济合理的治疗策略.
相关概念视频
01:15Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
381
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
381
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Methods Of Healthcare Delivery System
3.1K
At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is...
3.1K
01:22Heart Failure Drugs: β-Blockers
314
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
314
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338